Literature DB >> 15790776

Notch/Delta4 interaction in human embryonic liver CD34+ CD38- cells: positive influence on BFU-E production and LTC-IC potential maintenance.

Jonathan S Dando1, Manuela Tavian, Cyril Catelain, Sonia Poirault, Annelise Bennaceur-Griscelli, Françoise Sainteny, William Vainchenker, Bruno Péault, Evelyne Lauret.   

Abstract

We investigated whether Notch signaling pathways have a role in human developmental hematopoiesis. In situ histochemistry analysis revealed that Notch1, 2, and 4 and Notch ligand (Delta1-4, and Jagged1) proteins were not expressed in the yolk sac blood islands, the para-aortic splanchnopleure, the hematopoietic aortic clusters, and at the early stages of embryonic liver hematopoiesis. Notch1-2, and Delta4 were eventually detected in the embryonic liver, from 34 until 38 days postconception. Fluorescence-activated cell sorter analysis showed that first-trimester embryonic liver CD34(+)CD38(low) cells expressed both Notch1 and Notch2. When these cells were cultured on S17 stroma stably expressing Delta4, a 2.6-fold increase in BFU-E number was observed at day 7, as compared with cultures with control stroma, and this effect was maintained for 2 weeks. Importantly, exposure of these cells to Delta4 under these conditions maintained the original frequency and quality of long-term culture-initiating cells (LTC-ICs), while control cultures quickly resulted in the extinction of this LTC-IC potential. Furthermore, short-term exposure of embryonic liver adherent cells to erythropoietin resulted in a dose-dependent increase in Delta4 expression, almost doubling the expression observed with untreated stroma. This suggests that Delta4 has a role in the regulation of hematopoiesis after a hypoxic stress in the fetus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15790776     DOI: 10.1634/stemcells.2004-0205

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  17 in total

Review 1.  Notch signaling in hematopoietic stem cells.

Authors:  Takahiro Suzuki; Shigeru Chiba
Journal:  Int J Hematol       Date:  2005-11       Impact factor: 2.490

Review 2.  The regulatory role of stromal microenvironments in fetal hematopoietic ontogeny.

Authors:  Andrea T Badillo; Alan W Flake
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 3.  Notch signaling in differentiation and function of dendritic cells.

Authors:  Pingyan Cheng; Dmitry Gabrilovich
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

4.  Impaired embryonic haematopoiesis yet normal arterial development in the absence of the Notch ligand Jagged1.

Authors:  Alex Robert-Moreno; Jordi Guiu; Cristina Ruiz-Herguido; M Eugenia López; Julia Inglés-Esteve; Lluis Riera; Alex Tipping; Tariq Enver; Elaine Dzierzak; Thomas Gridley; Lluis Espinosa; Anna Bigas
Journal:  EMBO J       Date:  2008-06-05       Impact factor: 11.598

5.  Tumor-initiating stem-like cells and drug resistance: carcinogenesis through Toll-like receptors, environmental factors, and virus.

Authors:  Keigo Machida
Journal:  Drug Deliv Transl Res       Date:  2013-04       Impact factor: 4.617

Review 6.  Challenges and strategies for generating therapeutic patient-specific hemangioblasts and hematopoietic stem cells from human pluripotent stem cells.

Authors:  Ann Peters; Paul W Burridge; Marina V Pryzhkova; Michal A Levine; Tea-Soon Park; Christopher Roxbury; Xuan Yuan; Bruno Péault; Elias T Zambidis
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

7.  Existence of cancer stem cells in hepatocellular carcinoma: myth or reality?

Authors:  Keigo Machida
Journal:  Hepatol Int       Date:  2016-12-18       Impact factor: 6.047

8.  Oncogenic signaling pathways and origins of tumor-initiating stem-like cells of hepatocellular carcinomas induced by hepatitis C virus, alcohol and/or obesity.

Authors:  Chia-Lin Chen; Hidekazu Tsukamoto; Keigo Machida
Journal:  Hepatol Int       Date:  2014-06-20       Impact factor: 6.047

9.  Notch signaling specifies megakaryocyte development from hematopoietic stem cells.

Authors:  Thomas Mercher; Melanie G Cornejo; Christopher Sears; Thomas Kindler; Sandra A Moore; Ivan Maillard; Warren S Pear; Jon C Aster; D Gary Gilliland
Journal:  Cell Stem Cell       Date:  2008-09-11       Impact factor: 24.633

10.  The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling.

Authors:  L Lin; R Amin; G I Gallicano; E Glasgow; W Jogunoori; J M Jessup; M Zasloff; J L Marshall; K Shetty; L Johnson; L Mishra; A R He
Journal:  Oncogene       Date:  2009-01-12       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.